Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-07

Clinical Trial Update: Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating predictive factors for terminating paroxysmal atrial fibrillation by blocking atrial selective ionic currents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: David Filgueiras-Rama | Conditions: Paroxysmal Atrial Fibrillation | Phase 4 | Status: COMPLETED